J Vet Sci.  2012 Sep;13(3):235-244. 10.4142/jvs.2012.13.3.235.

Activation of Akt/protein kinase B mediates the protective effects of mechanical stretching against myocardial ischemia-reperfusion injury

Affiliations
  • 1Department of Public Health, Chengdu Medical College, Chengdu, Sichuan 610083, China.
  • 2Department of Pharmacology, College of Medicine, Chungbuk National University, Cheongju 361-763, Korea. kch@chungbuk.ac.kr
  • 3Department of Thoracic and Cardiovascular Surgery, College of Medicine, Chungbuk National University, Cheongju 361-763, Korea. ksw713@chungbuk.ac.kr

Abstract

Akt/protein kinase B is a well-known cell survival factor and activated by many stimuli including mechanical stretching. Therefore, we evaluated the cardioprotective effect of a brief mechanical stretching of rat hearts and determined whether activation of Akt through phosphatidylinositol 3-kinase (PI3K) is involved in stretch-induced cardioprotection (SIC). Stretch preconditioning reduced infarct size and improved post-ischemic cardiac function compared to the control group. Phosphorylation of Akt and its downstream substrate, GSK-3beta, was increased by mechanical stretching and completely blocked by wortmannin, a PI3K inhibitor. Treatment with lithium or SB216763 (GSK-3beta inhibitors) before ischemia induction mimicked the protective effects of SIC on rat heart. Gadolinium (Gd3+), a blocker of stretch-activated ion channels (SACs), inhibited the stretch-induced phosphorylation of Akt and GSK-3beta. Furthermore, SIC was abrogated by wortmannin and Gd3+. In vivo stretching induced by an aorto-caval shunt increased Akt phosphorylation and reduced myocardial infarction; these effects were diminished by wortmannin and Gd3+ pretreatment. Our results showed that mechanical stretching can provide cardioprotection against ischemia-reperfusion injury. Additionally, the activation of Akt, which might be regulated by SACs and the PI3K pathway, plays an important role in SIC.

Keyword

Akt/protein kinase B; cardioprotection; ischemia-reperfusion injury; mechanical stretching

MeSH Terms

Androstadienes/pharmacology
Animals
Gadolinium/pharmacology
Glycogen Synthase Kinase 3/*metabolism
Indoles/pharmacology
*Ischemic Preconditioning, Myocardial
Lithium/pharmacology
Male
Maleimides/pharmacology
Myocardial Reperfusion Injury/enzymology/physiopathology/*prevention & control
Phosphatidylinositol 3-Kinase/*antagonists & inhibitors/metabolism
Phosphorylation
Proto-Oncogene Proteins c-akt/*metabolism
Random Allocation
Rats
Rats, Sprague-Dawley
Specific Pathogen-Free Organisms

Figure

  • Fig. 1 Protocols for each experimental group showing the reagents used and time courses of the various treatments. (A) All ex vivo hearts underwent 30 min of sustained ischemia followed by 1 h reperfusion. (B) Experimental protocols for in vivo stretch preconditioning (SPC) showing the reagents used and time courses of the various treatments. I/R Con: ischemia-reperfusion control, IPC: ischemia preconditioning, LiCl: lithium chloride, WM: wortmannin, Gd3+: gadolinium, ACS: aorto-caval shunt.

  • Fig. 2 Effects of SPC on ex vivo hearts. (A) After each experimental treatment, sections of the hearts were stained with 2,3,5-triphenyl tetrazolium chloride (TTC). Normalized infarct sizes were then calculated and compared. All data are presented as the mean ± SE (n ≥ 6) for each experimental group. *p < 0.05 compared to the I/R Con group, †p < 0.05 compared to the SPC group. (B) Functional recovery of ex vivo stretched hearts. No significant differences were observed among the SPC, SB, and LiCl groups. All data are presented as the mean ± SE (n ≥ 6) for each experimental group. SB: SB216763, LVEDP: left ventricular end-diastolic pressure, LVDP: left ventricular developed pressure.

  • Fig. 3 Phosphorylation of Akt and GSK-3β in the ex vivo hearts. The levels of Akt and GSK-3β phosphorylation were compared before and after ischemia in hearts pretreated with wortmannin (A) or Gd3+ (B). (C) Akt and GSK-3β phosphorylation was analyzed with semi-quantitative densitometry before and after ischemia. The results presented are representative of six independent experiments. *p < 0.05 compared to the I/R Con group, †p < 0.05 compared to the SPC group. GSK-3β: glycogen synthase kinase-3β.

  • Fig. 4 Phosphorylation of Akt after ACS placement. After an ACS was created in the rats, Akt phosphorylation was measured at different time points with wortmannin and Gd3+ pretreatment. *p < 0.05 compared to the I/R Con group, †p < 0.05 compared to the 30 min ACS group. Sham: sham-operated hearts.

  • Fig. 5 In vivo effects of SPC on infarct size in rat heart. (A) Infarct size was measured after TTC stain. Scale bar = 10 mm. (B) Normalized infarct sizes were calculated and compared. All data are presented as the mean ± SE (n ≥ 6) for each experimental group. *p < 0.05 compared to the I/R Con group, †p < 0.05 compared to the 30-min ACS group.

  • Fig. 6 Proposed mechanism underlying mechanical stretch-induced cardioprotection against I/R injury in rat hearts. Akt is activated by mechanical stretching through SACs and consequently phosphorylates GSK-3β, thereby providing cardioprotection against I/R injury.


Reference

1. Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, Nagai R, Komuro I. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation. 2000. 102:2873–2879.
Article
2. Badorff C, Ruetten H, Mueller S, Stahmer M, Gehring D, Jung F, Ihling C, Zeiher AM, Dimmeler S. Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload. J Clin Invest. 2002. 109:373–381.
Article
3. Baines CP, Wang L, Cohen MV, Downey JM. Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart. Basic Res Cardiol. 1999. 94:188–198.
Article
4. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998. 282:1318–1321.
Article
5. Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res. 2006. 70:254–263.
Article
6. Force T, Michael A, Kilter H, Haq S. Stretch-activated pathways and left ventricular remodeling. J Card Fail. 2002. 8:6 Suppl. S351–S358.
Article
7. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997. 88:435–437.
Article
8. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation. 2000. 101:660–667.
Article
9. Gysembergh A, Margonari H, Loufoua J, Ovize A, André-Fouët X, Minaire Y, Ovize M. Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart. Am J Physiol Heart Circ Physiol. 1998. 274:H955–H964.
10. Haq S, Choukroun G, Kang ZB, Ranu H, Matsui T, Rosenzweig A, Molkentin JD, Alessandrini A, Woodgett J, Hajjar R, Michael A, Force T. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol. 2000. 151:117–129.
Article
11. Hardt SE, Sadoshima J. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ Res. 2002. 90:1055–1063.
12. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci. 2004. 25:259–264.
Article
13. Huang CH, Wang JS, Chiang SC, Wang YY, Lai ST, Weng ZC. Brief pressure overload of the left ventricle preconditions rabbit myocardium against infarction. Ann Thorac Surg. 2004. 78:628–633.
Article
14. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg. 1998. 65:748–753.
Article
15. Izuishi K, Tsung A, Hossain MA, Fujiwara M, Wakabayashi H, Masaki T, Billiar TR, Maeta H. Ischemic preconditioning of the murine liver protects through the Akt kinase pathway. Hepatology. 2006. 44:573–580.
Article
16. Jiao JD, Garg V, Yang B, Hu K. Novel functional role of heat shock protein 90 in ATP-sensitive K+ channel-mediated hypoxic preconditioning. Cardiovasc Res. 2008. 77:126–133.
Article
17. Kaukoranta PK, Lepojärvi MPK, Ylitalo KV, Kiviluoma KT, Peuhkurinen KJ. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg. 1997. 63:1268–1274.
Article
18. Kim CH, Cho YS, Chun YS, Park JW, Kim MS. Early expression of myocardial HIF-1α in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ Res. 2002. 90:E25–E33.
19. Kim CH, Choi H, Chun YS, Kim GT, Park JW, Kim MS. Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Pflugers Arch. 2001. 442:519–525.
Article
20. Kim YH, Kim CH, Kim GT, Kim IK, Park JW, Kim MS. Involvement of adenosine in cardioprotective effect of catecholamine preconditioning in ischemia-reperfused heart of rat. Korean J Physiol Pharmacol. 1998. 2:753–761.
21. Lammerding J, Kamm RD, Lee RT. Mechanotransduction in cardiac myocytes. Ann N Y Acad Sci. 2004. 1015:53–70.
Article
22. Li B, Setoguchi M, Wang X, Andreoli AM, Leri A, Malhotra A, Kajstura J, Anversa P. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res. 1999. 84:1007–1019.
Article
23. Ma XJ, Yin HJ, Guo CY, Jiang YR, Wang JS, Shi DZ. Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigs: roles of PI3K activation. Coron Artery Dis. 2012. 23:245–250.
Article
24. Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ, Rosenzweig A. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation. 1999. 100:2373–2379.
Article
25. Mosca SM. Cardioprotective effects of stretch are mediated by activation of sarcolemmal, not mitochondrial, ATP-sensitive potassium channels. Am J Physiol Heart Circ Physiol. 2007. 293:H1007–H1012.
Article
26. Nagaya N, Nishikimi T, Yoshihara F, Horio T, Morimoto A, Kangawa K. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am J Physiol Regul Integr Comp Physiol. 2000. 278:R1019–R1026.
Article
27. Nakagawa C, Asayama J, Katamura M, Matoba S, Keira N, Kawahara A, Tsuruyama K, Tanaka T, Kobara M, Akashi K, Ohta B, Tatsumi T, Nakagawa M. Myocardial stretch induced by increased left ventricular diastolic pressure preconditions isolated perfused hearts of normotensive and spontaneously hypertensive rats. Basic Res Cardiol. 1997. 92:410–416.
Article
28. Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol Heart Circ Physiol. 1994. 266:H137–H146.
Article
29. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, Takahashi T, Kato T, Ogawa S. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1999. 84:1127–1136.
Article
30. Pap M, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem. 1998. 273:19929–19932.
Article
31. Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Res Cardiol. 2003. 98:149–157.
32. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999. 401:86–90.
Article
33. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol. 2001. 2:760–768.
Article
34. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, Sato K, Zeng L, Schiekofer S, Pimentel D, Lecker S, Taegtmeyer H, Goldberg AL, Walsh K. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem. 2005. 280:20814–20823.
Article
35. Smith SC Jr. Reducing the global burden of ischemic heart disease and stroke. A challenge for the cardiovascular community and the United Nations. Circulation. 2011. 124:278–279.
Article
36. Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J Surg Res. 2008. 150:304–330.
Article
37. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res. 2000. 87:309–315.
Article
38. Vaage J, Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg. 2003. 75:S709–S714.
Article
39. Wei H, van der Heide RS. Ischemic preconditioning and heat shock activate Akt via a focal adhesion kinase-mediated pathway in Langendorff-perfused adult rat hearts. Am J Physiol Heart Circ Physiol. 2010. 298:H152–H157.
Article
40. Zhou H, Li XM, Meinkoth J, Pittman RN. Akt regulates cell survival and apoptosis at a postmitochondrial level. J Cell Biol. 2000. 151:483–494.
Article
Full Text Links
  • JVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr